FR167653 suppresses the progression of experimental autoimmune myocarditis

Molecular and Cellular Biochemistry

Volumn 246, Issue 1-2, 2003, Pages 39-44

  Maruyama, Seitaro ^a   Kato, Kiminori ^a   Kodama, Makoto ^a   Okura, Yuji ^a   Hirono, Satoru ^a   Fuse, Koichi ^a   Hanawa, Haruo ^a   Nakagawa, Osamu ^a   Nakazawa, Mikio ^a   Miida, Takashi ^a   Yaoita, Eisin ^a   Yamamoto, Tadashi ^a   Inoue, Ikuo ^b   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Experimental autoimmune myocarditis (EAM); FR1676532IL 1 ; Ribonuclease protection assay

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; CARDIAC MYOSIN; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; SIALIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; GENE EXPRESSION; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART WEIGHT; HEMODYNAMICS; HYPOTHESIS; IMMUNIZATION; INFLAMMATION; MALE; MYOCARDITIS; NONHUMAN; RAT;

ANIMALS; AUTOIMMUNE DISEASES; CARDIAC MYOSINS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1; MALE; MYOCARDITIS; PYRAZOLES; PYRIDINES; RATS; RATS, INBRED LEW; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 10744228792     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023447710638     Document Type: Article

References (33)

1. Davidoff R, Palacios I, Southern J, Fallon JT, Newell J, Dec GW: Giant cell vs. lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation 83: 953-961, 1991
2. Cooper LT Jr, Berry GJ, Shabetai R: Idiopathic giant-cell myocarditis - natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336: 1860-1866, 1997
3. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW: Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139: 3630-3636, 1987
4. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A: A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57: 250-262, 1990
5. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A: Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 75: 278-284, 1994
6. Smith SC, Allen PM: Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 147: 2141-2147, 1991
7. Kodama M, Matsumoto Y, Fujiwara M: In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 85: 1918-1926, 1992
8. Okura Y, Takeda K, Honda S, Hanawa H, Watanabe H, Kodama M, Izumi T, Aizawa Y, Seki S, Abo T: Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res 82: 1035-1042, 1998
9. Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson CB, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T: Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 29: 491-502, 1997
10. Smith SC, Allen PM: Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res 70: 856-863, 1992
11. Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M: Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol 314: 137-142, 1996
12. Aiba M, Takeyoshi I, Ohwada S, Kobayashi J, Iwanami K, Sunose Y, Kawashima Y, Mastumoto K, Muramoto M, Morishita Y: Optimal end point of FR167653 administration and expression of interleukin-8 messenger RNA on extended liver resection with ischemia in dogs. J Am Coll Surg 191: 251-258., 2000
13. Otani Y, Takeyoshi I, Koibuchi Y, Matsumoto K, Muramoto M, Morishita Y: The effect of FR167653 on pulmonary ischemia-reperfusion injury in rats. J Heart Lung Transplant 19: 377-383, 2000
14. Ohashi N, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, Miyamoto T, Nakano A, Sasayama S: Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 20: 2521-2526, 2000
15. Inomata T, Hanawa H, Miyanishi T, Yajima E, Nakayama S, Maita T, Kodama M, Izumi T, Shibata A, Abo T: Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circ Res 76: 726-733, 1995
16. Hirono S, Islam MO, Nakazawa M, Yoshida Y, Kodama M, Shibata A, Izumi T, Imai S: Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ Res 80: 11-20, 1997
17. Feng L, Tang WW, Loskutoff DJ, Wilson CB: Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 3: 1753-1764, 1993
18. Sambrook JF: Molecular Cloning. In: A Laboratory Manual. Cold Spring Harbor Lab., New York, 1989, pp 71-78
19. Yamamoto T, Sasaki S, Fushimi K, Ishibashi K, Yaoita E, Kawasaki K, Fujinaka H, Marumo F, Kihara I: Expression of AQP family in rat kidneys during development and maturation. Am J Physiol 272: F198-F204, 1997
20. Ponassi M, Jacques TS, Ciani L, Constant CF: Expression of the rat homologue of the Drosophila fat tumour suppressor gene. Mech Dev 80: 207-212, 1999
21. Masters DB, Griggs CT, Berde CB: High sensitivity quantification of RNA from gels and autoradiograms with affordable optical scanning. Biotechniques 12: 902-906, 908-911, 1992
22. Doumas BT, Watson WA, Biggs HG: Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31: 87-96, 1971
23. Sugahara K, Sugimoto K, Nomura O, Usui T: Enzymatic assay of serum sialic acid. Clin Chim Acta 108: 493-498, 1980
24. Sillanaukee P, Ponnio M, Jaaskelainen IP: Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin invest 29: 413-425, 1999
25. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333: 269-275, 1995
26. Kodama M, Oda H, Okabe M, Aizawa Y: Early and long-term mortality of the clinical subtypes of myocarditis. Jpn Circ J 65: 961-964, 2001
27. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342: 690-695, 2000
28. Mendes LA, Picard MH, Dec GW, Hartz VL, Palacios IF, Davidoff R: Ventricular remodeling in active myocarditis. Myocarditis Treatment Trial. Am Heart J 138: 303-308, 1999
29. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B: Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97: 1375-1381, 1998
30. Siwik DA, Chang DL, Colucci WS: Interleukin-1 beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86: 1259-1265, 2000
31. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R: Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87: 241-247, 2000
32. Zhang S, Kodama M, Hanawa H, Izumi T, Shibata A, Masani F: Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis. J Am Coll Cardiol 21: 1254-1260, 1993
33. Hanawa H, Kodama M, Zhang S, Izumi T, Shibata A: An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in rats. Clin Immunol Immunopathol 62: 321-326, 1992